These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17295655)

  • 21. Pegylated interferon monotherapy for chronic hepatitis C.
    Heathcote J; Zeuzem S
    Semin Liver Dis; 2004; 24 Suppl 2():39-45. PubMed ID: 15346245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
    Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
    J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis.
    Amarapurkar DN; Patel ND; Kirpalani AL
    Trop Gastroenterol; 2007; 28(1):16-8. PubMed ID: 17896604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peg-Interferon Alfa 2a (40kDa) in patients on chronic haemodialysis with chronic C hepatitis. Preliminary results.
    Sporea I; Sirli R; Golea O; Totolici C; Danila M; Popescu A
    Rom J Gastroenterol; 2004 Jun; 13(2):99-102. PubMed ID: 15229772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
    Tsubota A; Arase Y; Someya T; Suzuki Y; Suzuki F; Saitoh S; Ikeda K; Akuta N; Hosaka T; Kobayashi M; Kumada H
    J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.
    Ucmak H; Kokoglu OF; Hosoglu S; Dogan E; Sayarlioglu H; Kuzhan N; Isik IO
    Ren Fail; 2008; 30(2):227-32. PubMed ID: 18300126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
    Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
    New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
    Meyer-Wyss B; Rich P; Egger H; Helbling B; Müllhaupt B; Rammert C; Gonvers JJ; Oneta C; Criblez D; Rossi L; Borovicka J; Meyenberger C; Arn M; Renner EL;
    J Viral Hepat; 2006 Jul; 13(7):457-65. PubMed ID: 16792539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.
    Kamar N; Abravanel F; Garrouste C; Cardeau-Desangles I; Mansuy JM; Weclawiak H; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2792-5. PubMed ID: 20494897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated interferon for treatment of chronic hepatitis C in hemodialysis patients in Croatia.
    Basic-Jukic N; Gulin M; Slavicek J; Coric-Martinovic V; Iskra B; Racki S; Sain M; Ostojić R; Hrstic I; Ljutic D; Vucelic B; Kes P
    Kidney Blood Press Res; 2011; 34(1):53-7. PubMed ID: 21212685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.
    Hayashi N; George J; Shiroeda H; Saito T; Toshikuni N; Tsuchishima M; Arisawa T; Tsutsumi M
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1015-8. PubMed ID: 23425065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
    Kojima A; Kakizaki S; Hosonuma K; Yamazaki Y; Horiguchi N; Sato K; Kitahara T; Mori M
    J Gastroenterol Hepatol; 2013 Apr; 28(4):690-9. PubMed ID: 23302054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C].
    Tae HJ; Jun DW; Choi JW; Kim WJ; Kim BY; Sohn JH; Lee MH
    Korean J Gastroenterol; 2011 Dec; 58(2):107-10. PubMed ID: 21873827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.
    Sporea I; Popescu A; Sirli R; Golea O; Totolici C; Danila M; Vernic C
    World J Gastroenterol; 2006 Jul; 12(26):4191-4. PubMed ID: 16830372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Good virological response to pegylated interferon alfa monotherapy of chronic hepatitis C infection in hemodialysis patient].
    Caro P; Núñez A; Delgado R; Dapena F; Amann R
    Nefrologia; 2007; 27(1):77-80. PubMed ID: 17402884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Med Virol; 2010 May; 82(5):768-75. PubMed ID: 20336712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C.
    Russo MW; Ghalib R; Sigal S; Joshi V
    Nephrol Dial Transplant; 2006 Feb; 21(2):437-43. PubMed ID: 16234288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
    Ayaz C; Celen MK; Yuce UN; Geyik MF
    World J Gastroenterol; 2008 Jan; 14(2):255-9. PubMed ID: 18186564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with peg-interferon-alpha of patients with chronic hepatitis C].
    Barbakadze EI; Pipin GV; Kamkamidze GK
    Ter Arkh; 2005; 77(2):73-5. PubMed ID: 15807458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.